E

Researcher Profile

Emily Riser

1

Publications

100

Citations

10

Co-Authors

1

Active Years

Publications

Journal Article The Lancet Neurology Jul 01, 2022

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial

John F Foley · Gilles Defer · Lana Zhovtis Ryerson · Jeffrey A Cohen +96 more

10.1016/s1474-4422(22)00143-0 100 citations

Publication Timeline

2022

1

Frequent Co-Authors

Salvatore Napoli

Nikolaos Evangelou

Christopher Dwyer